The bioregulatory drug traumeel s in locomotor diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper considers the efficiency and safety of using Traumeel S to treat locomotor diseases. It summarizes the data of clinical trials of the efficacy and safety of its various formulations.

Full Text

Restricted Access

About the authors

A. Pilipovich

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: aapilipovich@mail.ru

References

  1. Биорегуляторный подход в терапии болевых синдромов в опорно-двигательном аппарате. Практические аспекты применения комплексных антигомотоксических препаратов. Монография / Biologische Heilmittel Heel GmbH, 2015; 40 с.
  2. Ван Хазелен Р. Лекарственный препарат Траумель С: интегративный обзор доказательств эффективности // Врач. - 2017; 3: 46-52.
  3. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. CEBM Web site. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies